Advertisement
New Zealand markets closed
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NZD/USD

    0.5941
    -0.0008 (-0.14%)
     
  • NZD/EUR

    0.5549
    +0.0009 (+0.16%)
     
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD

    2,349.60
    +7.10 (+0.30%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • NZD/JPY

    94.0360
    +1.5400 (+1.66%)
     

Toyota (TM) Q4 Earnings & Revenues Beat, FY22 View Upbeat

Toyota Motor TM posted fiscal fourth-quarter 2021 earnings of $5.18 per share, which handily surpassed the Zacks Consensus Estimate of $3.45 on higher-than-expected revenues. Moreover, the bottom line jumped from the year-ago earnings of 45 cents a share. Consolidated revenues came in at $72,564.3 million, beating the consensus mark of $70,780 million. The top-line figure also climbed 11.3% year over year.

Segmental Results

The Automotive segment’s net revenues for the fiscal fourth quarter increased 13.2% year over year to ¥7 trillion ($66.45 billion). Operating profit came in at ¥548.7 billion ($5.18 billion), up 64.3% year over year.

The Financial Services segment’s net revenues inched down 1.4% from the prior-year quarter to ¥541.1 billion ($5.1 billion). The segment registered an operating income of ¥97.9 billion ($0.92 billion), turning around from fourth-quarter fiscal 2020 loss of ¥15.1 billion.

ADVERTISEMENT

All Other businesses’ net revenues improved 23.6% from the year-ago period to ¥346 billion ($3.3 billion) for the reported quarter. Further, operating income rose 6.5% year on year to ¥36.3 billion ($343 million).

Financial Position

Toyota had cash and cash equivalents of ¥3.3 trillion ($29.6 billion) as of Mar 31, 2021. Long-term debt amounted to ¥12 trillion ($108.9 billion). Operating cash flow for fiscal 2021 was ¥2,634.2 billion.

Fiscal 2021 Guidance Updated

Toyota — whose peers include Honda Motor HMC, Volkswagen VWAGY and General Motors GM — projects fiscal 2022 consolidated vehicle sales of 10.5 million units, indicating an increase from 9.9 million units sold in fiscal 2021. Sales are expected to total ¥30 trillion, implying a year-over-year increase of 10.2%. Operating income is now projected at ¥2.5 trillion, pointing to growth of 13.8% year over year. The company’s R&D expenses are likely to be ¥1,160 billion, suggesting an increase from ¥1,090 billion spent in fiscal 2021. Capex is envisioned at ¥1.35 trillion, indicating an increase from the ¥1.29 trillion spent in fiscal 2021.

Time to Invest in Legal Marijuana

If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.

After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%

You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.

Today, Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Honda Motor Co., Ltd. (HMC) : Free Stock Analysis Report
 
Toyota Motor Corporation (TM) : Free Stock Analysis Report
 
General Motors Company (GM) : Free Stock Analysis Report
 
Volkswagen AG (VWAGY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research